InsiderClue
Insiders · Profile

Adams Brian

Chief Legal Officer at Kymera Therapeutics · Chief Legal Officer at Relay Therapeutics. Filing since 20 Jul 2020. CIK 0001636994

KYMR Kymera Therapeutics, Inc. Chief Legal Officer · 1 trade RLAY Relay Therapeutics, Inc. Chief Legal Officer · 40 trades
Company
Date
Role
Action
Shares
Amount
Of holding
KYMR Kymera Therapeutics, Inc.
4 Sep 2026
Chief Legal Officer
Sold at will
6,371
$744.30K
11.3%
RLAY Relay Therapeutics, Inc.
29 Jul 2025
Chief Legal Officer
Sold at will
18,276
$67.26K
4.7%
RLAY Relay Therapeutics, Inc.
28 Jul 2025
Chief Legal Officer
Sold at will
1,637
$6.12K
0.4%
RLAY Relay Therapeutics, Inc.
30 Apr 2025
Chief Legal Officer
Sold at will
12,943
$38.83K
3.2%
RLAY Relay Therapeutics, Inc.
28 Apr 2025
Chief Legal Officer
Sold at will
1,644
$5.21K
0.4%
RLAY Relay Therapeutics, Inc.
27 Mar 2025
Chief Legal Officer
Sold at will
298
$846.32
0.1%
RLAY Relay Therapeutics, Inc.
30 Jan 2025
Chief Legal Officer
Sold at will
20,791
$91.90K
4.9%
RLAY Relay Therapeutics, Inc.
28 Jan 2025
Chief Legal Officer
Sold at will
33,688
$155.98K
10.5%
RLAY Relay Therapeutics, Inc.
27 Dec 2024
Chief Legal Officer
Sold at will
299
$1.31K
0.1%
RLAY Relay Therapeutics, Inc.
28 Oct 2024
Chief Legal Officer
Sold at will
1,632
$9.89K
0.5%
RLAY Relay Therapeutics, Inc.
27 Sep 2024
Chief Legal Officer
Sold at will
295
$2.22K
0.1%
RLAY Relay Therapeutics, Inc.
29 Jul 2024
Chief Legal Officer
Sold at will
1,638
$14.50K
0.5%
RLAY Relay Therapeutics, Inc.
27 Jun 2024
Chief Legal Officer
Sold at will
295
$1.85K
0.1%
RLAY Relay Therapeutics, Inc.
29 Apr 2024
Chief Legal Officer
Sold at will
1,623
$10.35K
0.5%
RLAY Relay Therapeutics, Inc.
27 Mar 2024
Chief Legal Officer
Sold at will
348
$2.68K
0.1%
RLAY Relay Therapeutics, Inc.
29 Jan 2024
Chief Legal Officer
Sold at will
1,929
$18.60K
0.6%
RLAY Relay Therapeutics, Inc.
27 Dec 2023
Chief Legal Officer
Sold at will
294
$3.38K
0.2%
RLAY Relay Therapeutics, Inc.
30 Oct 2023
Chief Legal Officer
Sold at will
1,632
$9.84K
1.2%
RLAY Relay Therapeutics, Inc.
27 Sep 2023
Chief Legal Officer
Sold at will
294
$2.46K
0.2%
RLAY Relay Therapeutics, Inc.
28 Jul 2023
Chief Legal Officer
Sold at will
1,628
$19.21K
1.2%
RLAY Relay Therapeutics, Inc.
27 Jun 2023
Chief Legal Officer
Sold at will
294
$3.56K
0.2%
RLAY Relay Therapeutics, Inc.
28 Apr 2023
Chief Legal Officer
Sold at will
863
$9.63K
0.6%
RLAY Relay Therapeutics, Inc.
27 Mar 2023
Chief Legal Officer
Sold at will
347
$5.33K
0.3%
RLAY Relay Therapeutics, Inc.
30 Jan 2023
Chief Legal Officer
Sold, plan not stated
864
$18.63K
0.6%
RLAY Relay Therapeutics, Inc.
12 Jan 2023
Chief Legal Officer
Sold, plan not stated
9,994
$199.88K
16.2%
RLAY Relay Therapeutics, Inc.
27 Dec 2022
Chief Legal Officer
Sold, plan not stated
295
$4.27K
0.5%
RLAY Relay Therapeutics, Inc.
28 Oct 2022
Chief Legal Officer
Sold, plan not stated
728
$15.68K
1.2%
RLAY Relay Therapeutics, Inc.
27 Sep 2022
Chief Legal Officer
Sold, plan not stated
294
$6.68K
0.5%
RLAY Relay Therapeutics, Inc.
28 Jul 2022
Chief Legal Officer
Sold, plan not stated
734
$15.61K
1.2%
RLAY Relay Therapeutics, Inc.
27 Jun 2022
Chief Legal Officer
Sold, plan not stated
300
$6.09K
0.5%
RLAY Relay Therapeutics, Inc.
28 Apr 2022
Chief Legal Officer
Sold, plan not stated
708
$18.10K
1.1%
RLAY Relay Therapeutics, Inc.
29 Mar 2022
Chief Legal Officer
Sold, plan not stated
333
$9.95K
0.5%
RLAY Relay Therapeutics, Inc.
27 Dec 2021
General Counsel
Sold, plan not stated
295
$9.76K
1.2%
RLAY Relay Therapeutics, Inc.
15 Nov 2021
General Counsel
Sold, plan not stated
6,500
$230.23K
20.5%
RLAY Relay Therapeutics, Inc.
27 Sep 2021
General Counsel
Sold, plan not stated
293
$10.80K
1.1%
RLAY Relay Therapeutics, Inc.
13 Sep 2021
General Counsel
Sold, plan not stated
6,500
$227.63K
20.3%
RLAY Relay Therapeutics, Inc.
28 Jun 2021
General Counsel
Sold, plan not stated
293
$10.49K
1.1%
RLAY Relay Therapeutics, Inc.
7 Jun 2021
General Counsel
Sold, plan not stated
6,500
$227.50K
20.1%
RLAY Relay Therapeutics, Inc.
26 Apr 2021
General Counsel
Sold, plan not stated
6,500
$227.50K
20.1%
RLAY Relay Therapeutics, Inc.
28 Jan 2021
General Counsel
Sold, plan not stated
5,000
$275.25K
33.3%
RLAY Relay Therapeutics, Inc.
20 Jul 2020
General Counsel
Bought
10,000
$200.00K
opened
41 decisions on file.